A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC

NCT02852083 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Lung Cancer
Non-Squamous Cell Lung Cancer
Non-Small Cell Lung Cancer

Interventions

DRUG: Pioglitazone
DRUG: nivolumab
DRUG: Treosulfan
DRUG: Clarithromycin

Sponsor

University Hospital Regensburg

Collaborators

[object Object]